Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.45 Insider Own31.78% Shs Outstand286.85M Perf Week9.03%
Market Cap1.40B Forward P/E- EPS next Y-0.50 Insider Trans0.00% Shs Float197.97M Perf Month17.23%
Income-129.14M PEG- EPS next Q-0.11 Inst Own38.97% Short Float / Ratio13.87% / 17.00 Perf Quarter-13.60%
Sales50.39M P/S27.81 EPS this Y-191.00% Inst Trans11.58% Short Interest27.47M Perf Half Y-28.87%
Book/sh4.12 P/B1.17 EPS next Y-8.95% ROA-8.43% Target Price20.75 Perf Year-62.47%
Cash/sh2.79 P/C1.73 EPS next 5Y10.00% ROE-10.62% 52W Range3.87 - 13.78 Perf YTD-52.32%
Dividend- P/FCF- EPS past 5Y308.35% ROI-10.27% 52W High-64.95% Beta0.28
Dividend %- Quick Ratio8.33 Sales past 5Y507.44% Gross Margin- 52W Low24.81% ATR0.27
Employees495 Current Ratio8.34 Sales Q/Q-93.49% Oper. Margin-411.53% RSI (14)60.29 Volatility7.44% 6.62%
OptionableYes Debt/Eq0.07 EPS Q/Q-217.20% Profit Margin-256.27% Rel Volume1.27 Prev Close4.71
ShortableYes LT Debt/Eq0.06 EarningsNov 02 AMC Payout0.00% Avg Volume1.62M Price4.83
Recom1.22 SMA209.15% SMA509.65% SMA200-22.74% Volume2,051,996 Change2.55%
Date Action Analyst Rating Change Price Target Change
Nov-06-23Downgrade The Benchmark Company Buy → Hold
Oct-13-23Resumed Piper Sandler Overweight $20
Feb-28-23Initiated Cowen Outperform
Dec-15-22Initiated Goldman Buy $30
Nov-16-22Initiated Truist Buy $29
Dec-21-21Initiated The Benchmark Company Buy $27
Nov-19-21Initiated Piper Sandler Overweight $33
Jan-05-21Initiated SVB Leerink Outperform $45
Jan-05-21Initiated Stifel Buy $59
Jan-05-21Initiated Credit Suisse Outperform $52
Nov-16-23 04:05PM
Nov-03-23 12:05PM
05:30AM Loading…
Nov-02-23 05:56PM
Nov-01-23 04:05PM
Oct-31-23 04:05PM
Oct-26-23 10:02AM
Oct-11-23 04:05PM
Sep-29-23 12:43PM
Sep-27-23 09:00AM
Sep-20-23 05:02PM
07:03PM Loading…
Sep-14-23 07:03PM
Sep-13-23 09:00AM
Aug-31-23 10:12PM
Aug-19-23 10:44AM
Aug-04-23 10:23AM
Aug-03-23 05:35PM
Jul-26-23 01:17PM
Jul-25-23 09:55AM
Jul-24-23 04:05PM
Jul-08-23 08:43PM
Jul-06-23 04:05PM
Jun-17-23 09:52AM
06:50AM Loading…
May-30-23 06:50AM
May-29-23 04:05PM
May-27-23 08:43AM
May-24-23 02:32PM
May-14-23 02:57PM
May-06-23 08:03AM
May-05-23 10:13AM
May-04-23 05:15PM
Apr-27-23 10:02AM
Apr-24-23 07:46PM
Apr-17-23 09:10AM
Apr-13-23 05:50AM
Apr-11-23 07:31PM
Apr-06-23 04:05PM
Apr-05-23 01:40PM
Mar-22-23 03:26PM
Mar-14-23 04:30PM
Mar-12-23 08:09AM
Feb-23-23 04:05PM
Feb-21-23 10:30PM
Feb-02-23 02:19PM
Feb-01-23 04:05PM
Jan-24-23 04:05PM
Jan-23-23 11:00AM
Jan-19-23 07:00PM
Jan-12-23 04:55AM
Jan-05-23 09:09AM
Jan-04-23 04:05PM
Dec-22-22 05:08AM
Dec-21-22 06:46AM
Dec-16-22 10:02AM
Dec-15-22 07:00AM
Dec-14-22 08:18AM
Dec-12-22 08:54AM
Dec-01-22 07:00AM
Nov-29-22 04:10PM
Nov-10-22 08:05AM
Nov-08-22 11:00PM
Nov-04-22 04:05PM
Nov-03-22 01:45PM
Nov-02-22 09:00AM
Nov-01-22 10:01AM
Oct-25-22 02:45PM
Oct-21-22 09:55AM
Oct-11-22 04:05PM
Oct-10-22 08:48AM
Oct-05-22 09:25AM
Oct-03-22 06:45AM
Sep-26-22 09:21AM
Sep-21-22 08:00AM
Aug-24-22 06:15AM
Aug-18-22 08:50AM
Aug-10-22 01:20PM
Aug-09-22 06:05PM
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Veronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hansen Carl L. G.Chief Executive OfficerMay 26Option Exercise2.7056,125151,538561,250May 30 01:14 PM
Thermopylae Holdings Ltd.10% OwnerMay 26Buy6.52153,000997,72856,012,493May 26 02:50 PM
Booth AndrewChief Financial OfficerMay 26Buy6.8514,50099,325153,000May 26 02:53 PM
Lecault VeroniqueChief Operating OfficerMay 05Option Exercise0.19250,00047,5002,020,122May 09 03:02 PM
Hansen Carl L. G.Chief Executive OfficerFeb 22Option Exercise2.7056,125151,538505,125Feb 23 04:33 PM
Booth AndrewChief Financial OfficerDec 20Option Exercise0.1950,0009,500188,500Dec 22 02:31 PM
Thermopylae Holdings Ltd.10% OwnerDec 16Buy10.1085,102859,24955,859,493Dec 20 10:18 AM